Over 200 biopharma investors and firms sign an open letter urging EU governments to boost life science investment as US trade pressure mounts.
June 29, 2026 01:18 PM EDT
PharmaManufacturing
Biopharma investors urge EU to boost life sciences amid US pricing pressure
Anna Brown
News Reporter
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries are calling for a…
In Europe, two divergent paths are emerging as countries grapple with what to do about drug prices, affecting both pharma and…
Investor coalition urges EU to direct part of Europe’s €10 trillion pension assets into life sciences
The pricing standoff between government and industry has stalled research and put thousands of jobs at risk
Companies have long lamented Europe's fragmented capital markets, single-market adoption on pricing and clinical trials, and…
A number of global pharma firms have pulled or paused U.K. investment plans amid waning government support and drug pricing talks.
